Dr Rachel Giles talks about the Medicom Conference Highlights from the UEGW 2020:
- Sands et al. Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease
- Ungaro et al. Risk factors for severe COVID-19 among IBD patients
- El-Salhy et al. Sustained response to faecal microbiota transplantation
- Quigley et al. Plecanatide effective for IBS with constipation
- Dellon et al. Dupilumab improves in diverse aspects of eosinophilic oesophagitis
Posted on
Table of Contents: UEGW 2020
Featured articles
Risk factors for severe COVID-19 among IBD patients
UEGW Round-Up Articles
Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease
Low-FODMAPs diet does not improve PPI-refractory GERD
Probiotic provides a potential adjuvant treatment to gluten-free diet
Cholecystectomy does not affect mortality in elderly patients
No improvements of remission with etrolizumab in ulcerative colitis
Filgotinib effective as maintenance treatment for ulcerative colitis
Possible causal link between eosinophilic inflammation and anxiety
Dupilumab improves in diverse aspects of eosinophilic oesophagitis
Plecanatide effective for IBS with constipation
Sustained response to faecal microbiota transplantation
Endoscopy can be delivered safely during the COVID-19 pandemic
Adenoma detection rate improves over time
Post-colonoscopy colorectal cancers in IBD patients
Risk factors for severe COVID-19 among IBD patients
First randomised T2T trial using endoscopy to guide dose escalation
site created by:
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com